vs
Side-by-side financial comparison of BioLineRx Ltd. (BLRX) and QUICKLOGIC Corp (QUIK). Click either name above to swap in a different company.
QUICKLOGIC Corp is the larger business by last-quarter revenue ($5.7M vs $5.4M, roughly 1.1× BioLineRx Ltd.). BioLineRx Ltd. runs the higher net margin — 9.0% vs -5.4%, a 14.3% gap on every dollar of revenue. QUICKLOGIC Corp produced more free cash flow last quarter ($-1.2M vs $-25.5M).
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.
QuickLogic Corp is a fabless semiconductor company developing low-power customizable FPGAs, embedded FPGA IP, and edge sensor processing solutions. Its offerings serve global wearables, IoT, mobile electronics, and industrial markets, enabling energy-efficient low-latency on-device processing for edge AI and sensing use cases.
BLRX vs QUIK — Head-to-Head
Income Statement — Q2 FY2024 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $5.4M | $5.7M |
| Net Profit | $484.0K | $-305.0K |
| Gross Margin | 83.4% | 62.7% |
| Operating Margin | -107.0% | 2.6% |
| Net Margin | 9.0% | -5.4% |
| Revenue YoY | — | -24.1% |
| Net Profit YoY | 102.6% | -114.9% |
| EPS (diluted) | $0.00 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $4.2M | ||
| Q2 24 | $5.4M | $4.1M | ||
| Q1 24 | — | $5.7M | ||
| Q4 23 | — | $6.7M | ||
| Q3 23 | — | $2.9M | ||
| Q2 23 | $0 | $4.1M |
| Q4 24 | — | $-305.0K | ||
| Q3 24 | — | $-2.1M | ||
| Q2 24 | $484.0K | $-1.6M | ||
| Q1 24 | — | $108.0K | ||
| Q4 23 | — | $1.2M | ||
| Q3 23 | — | $-2.3M | ||
| Q2 23 | $-18.5M | $-1.2M |
| Q4 24 | — | 62.7% | ||
| Q3 24 | — | 59.1% | ||
| Q2 24 | 83.4% | 54.7% | ||
| Q1 24 | — | 67.1% | ||
| Q4 23 | — | 76.9% | ||
| Q3 23 | — | 41.2% | ||
| Q2 23 | — | 57.8% |
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | -38.1% | ||
| Q2 24 | -107.0% | -29.3% | ||
| Q1 24 | — | 2.3% | ||
| Q4 23 | — | 19.2% | ||
| Q3 23 | — | -76.2% | ||
| Q2 23 | — | -26.6% |
| Q4 24 | — | -5.4% | ||
| Q3 24 | — | -49.8% | ||
| Q2 24 | 9.0% | -37.8% | ||
| Q1 24 | — | 1.9% | ||
| Q4 23 | — | 17.9% | ||
| Q3 23 | — | -77.7% | ||
| Q2 23 | — | -29.7% |
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $-0.14 | ||
| Q2 24 | $0.00 | $-0.11 | ||
| Q1 24 | — | $0.01 | ||
| Q4 23 | — | $0.08 | ||
| Q3 23 | — | $-0.17 | ||
| Q2 23 | $-0.02 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.6M | — |
| Total DebtLower is stronger | — | $3.1M |
| Stockholders' EquityBook value | $13.9M | $24.9M |
| Total Assets | $64.6M | $51.9M |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $9.6M | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | $10.1M | — |
| Q4 24 | — | $3.1M | ||
| Q3 24 | — | $3.4M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $1.4M | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 24 | — | $24.9M | ||
| Q3 24 | — | $20.9M | ||
| Q2 24 | $13.9M | $21.8M | ||
| Q1 24 | — | $22.2M | ||
| Q4 23 | — | $14.0M | ||
| Q3 23 | — | $12.2M | ||
| Q2 23 | $21.1M | $13.7M |
| Q4 24 | — | $51.9M | ||
| Q3 24 | — | $49.7M | ||
| Q2 24 | $64.6M | $47.5M | ||
| Q1 24 | — | $51.9M | ||
| Q4 23 | — | $36.5M | ||
| Q3 23 | — | $34.4M | ||
| Q2 23 | $58.9M | $34.7M |
| Q4 24 | — | 0.12× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | 0.06× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.4M | $116.0K |
| Free Cash FlowOCF − Capex | $-25.5M | $-1.2M |
| FCF MarginFCF / Revenue | -472.8% | -20.6% |
| Capex IntensityCapex / Revenue | 1.1% | 22.6% |
| Cash ConversionOCF / Net Profit | -52.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 24 | — | $116.0K | ||
| Q3 24 | — | $-16.0K | ||
| Q2 24 | $-25.4M | $-220.0K | ||
| Q1 24 | — | $147.0K | ||
| Q4 23 | — | $130.0K | ||
| Q3 23 | — | $38.0K | ||
| Q2 23 | $-17.7M | $-359.0K |
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-83.0K | ||
| Q2 24 | $-25.5M | $-4.2M | ||
| Q1 24 | — | $62.0K | ||
| Q4 23 | — | $-1.5M | ||
| Q3 23 | — | $-47.0K | ||
| Q2 23 | $-17.8M | $-361.0K |
| Q4 24 | — | -20.6% | ||
| Q3 24 | — | -2.0% | ||
| Q2 24 | -472.8% | -102.2% | ||
| Q1 24 | — | 1.1% | ||
| Q4 23 | — | -22.7% | ||
| Q3 23 | — | -1.6% | ||
| Q2 23 | — | -8.7% |
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | 1.1% | 96.9% | ||
| Q1 24 | — | 1.5% | ||
| Q4 23 | — | 24.7% | ||
| Q3 23 | — | 2.9% | ||
| Q2 23 | — | 0.0% |
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -52.56× | — | ||
| Q1 24 | — | 1.36× | ||
| Q4 23 | — | 0.11× | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLRX
Segment breakdown not available.
QUIK
| North America | $3.0M | 53% |
| Other | $2.7M | 47% |
